Clinical Research Directory
Browse clinical research sites, groups, and studies.
ULTRA-LAP Trial: Laparoscopic Debulking Surgery (LDS) in Advanced Ovarian Cancer
Sponsor: Azienda Ospedaliera di Padova
Summary
ULTRA-LAP is a prospective study is to investigate the safety, efficacy and feasibility of laparoscopic debulking surgery (LDS) for the treatment of patients with advanced ovarian cancer. The outcomes to measure are: * Safety: the rate of patients experiencing intra- and post-operative early and late morbidities (within the hospitalization and up to 60 days from surgery) * Efficacy: the rate of patients in which the surgical target set pre-operatively (complete resection) is achieved by laparoscopy. * Feasibility: the rate of patients who have their procedure completed by laparoscopy Patients will undergo laparoscopic debulking surgery (LDS) if the surgical target can be met. If it cannot be achieved by laparoscopy the surgeon will convert to laparotomy.
Official title: ULTRA-LAP Trial: Laparoscopic Debulking Surgery (LDS) in Advanced Ovarian Cancer: a Feasibility Prospective Study
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
62
Start Date
2022-01-02
Completion Date
2027-12-31
Last Updated
2023-05-17
Healthy Volunteers
No
Conditions
Interventions
Laparoscopic Debulking Surgery in advanced ovarian cancer
Laparoscopic debulking will be conducted until the surgical target is achieved or the operation is converted to laparotomy.
Standard laparotomic Debulking Surgery in advanced ovarian cancer
Debulking by laparotomy in patients when debulking could not be accomplished by laparoscopy.
Locations (1)
Azienda Ospedaliera Universitaria di Padova,
Padova, Padova, Veneto, Italy